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Edited by Jesus AvilaAbstract Preﬁbrillar cytotoxicity was suggested as a common
amyloid characteristic. We showed two types of albebetin pre-
ﬁbrillar oligomers are formed during incubation at pH 7.3. Ini-
tial round-shaped oligomers consist of 10–15 molecules
determined by atomic force microscopy, do not bind thioﬂavin-
T and do not aﬀect viability of granular neurons and SH-
SY5Y cells. They are converted into ca. 30–40-mers possessing
cross-b-sheet and reducing viability of neuronal cells. Neither
monomers nor ﬁbrils possess cytotoxicity. We suggest that olig-
omeric size is important for stabilising cross-b-sheet core critical
for cytotoxicity. As albebetin was used as a carrier-protein for
drug delivery, examination of amyloidogenicity is required prior
polypeptide biomedical applications.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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microscopy1. Introduction
It is widely accepted that aggregated forms associated with
amyloid diseases are critically involved in cellular toxicity
and tissue damage. However the deﬁnition of the toxic amy-
loid species and their particular structural properties exerting
the speciﬁc cytotoxic eﬀect remain controversial. In the last
years a number of studies have supported the hypothesis that
early aggregates or preﬁbrillar species are implicated in cyto-
toxicity while ﬁbrillar amyloid deposits serve as an escape
route for smaller aggregates [1–5]. Among them Kayed et al.
observed that intermediate-size water soluble oligomers of
Ab1–40 and other ﬁve proteins form sheared structures charac-
terized by similar conformational epitope, suggesting that they
exert cytotoxicity via similar mechanisms [6]. The ﬁnding that
disease non-related proteins SH3 domain and HypF can form
transient toxic amyloid oligomers led to suggestion that amy-
loid toxicity is a generic phenomenon which can be attributed
to many naturally occurring proteins [7]. Recently reported
cytotoxicity of transient amyloid oligomers of lysozyme is par-
ticularly important as it is a naturally abundant protein pres-Abbreviations: AFM, atomic force microscopy; CD, circular dichro-
ism; SPIP, scanning probe image processor
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that amyloid toxicity occurs under variety of conditions in
our daily life [8].
Currently, a broad range of structures are considered to be
cytotoxic including misfolded monomer and hexamer of trans-
thyretin [9], 8–9 nm globular structures of transthyretin mu-
tants [2], 8 to 20-mers of equine lysozyme [8], 4–200 nm
diameter granules of PI3-SH3 domain and short aggregates
of 4–8 nm width of HypF [10], 3–5 nm spherical aggregates
of a-synuclein [11,12], 90 kDa oligomers of Ab1–42 [13] and
others. Even the process of nucleation dependent polymeriza-
tion of Ab1–40 itself was suggested to be a primarily cause of
cytotoxicity [14]. As amyloid structures formed of many pro-
teins have been found to be also highly heterogeneous within
the same specimen and largely aﬀected by environmental con-
ditions and history of the sample, this hampers the clear
description of toxic species [3,15,16].
In our studies we have focused on characterization of the
amyloid cytotoxicity of de novo protein albebetin. Albebetin
was engineered as a protein with pre-determined 3D structure
[17] and it was used as an inert carrier matrix for drug delivery
[18–20]. It is a 73 amino acid residue protein composed of two
sets of abb motives forming four stranded b-sheet covered by
two a-helices and characterized by a mobile molten globule
type conformation at neutral pH. The compactness of this
molecule is achieved due to short loops connecting the second-
ary structure elements. In our previous studies we have shown
that albebetin readily assembles into a variety of amyloid
structures during its incubation under physiological conditions
[21]. Here we examine the cytotoxic properties of main amy-
loid species of albebetin relating their structural properties
with exerted cytotoxicity. The advantage of using albebetin
as a structural model for cytotoxicity studies lies in its ability
to convert into amyloid under conditions closely resembling
those of the cytotoxicity assays and therefore little perturba-
tion of toxic species occurs in the course of the experiment.
Taking into account that albebetin is a possible drug delivery
agent, examination of its cytotoxic properties is also important
for its potential biomedical applications.2. Materials and methods
2.1. Protein samples
Albebetin was expressed in Escherichia coli and puriﬁed as de-
scribed previously [18]. Its concentration was determined by using
Bradford assay. In order to produce amyloid structures albebetination of European Biochemical Societies.
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fer, 50 mM NaCl, 0.2% sodium azide, pH 7.4. Ab25–35 and cell apop-
totic agent D-sphingosine were purchased from Sigma (USA). Ab25–35
amyloid was produced upon 3 days of incubation at the same condi-
tions as albebetin.
2.2. Spectroscopic characterisation of amyloid formation
Thioﬂavine-T binding amyloid assay was carried out by using a
modiﬁcation of the method of Levine [22]. Fluorescence measurements
were performed on a Jasco spectroﬂuorometer FP 6500 (Japan) with
excitation at 440 nm and emission collected between 450 and
550 nm, setting the excitation and emission slits at 5 nm.
Congo red binding assay was performed according to the procedure
described in [23]. Optical absorbance spectra were recorded on a
NanoDrop ND-1000 spectrophotometer (USA).
Far UV circular dichroism (CD) spectra were collected on a Jasco
J720 CD UV spectrometer (Japan) equipped with a water bath temper-
ature controller using a 1 mm light path quartz cell.
2.3. Neuronal cells
Cerebellar granular neurons were extracted from cerebellum of 8
days aged male Wistar rats. Cerebellum tissues were incubated in
Krebs-Ringer solution (120 mM NaCl, 4.8 mM KCl, 1.2 mM
KH2PO4, 25 mM NaHCO3, 14 mM glucose, 0.3% BSA) with 0.25%
trypsin. Cells were suspended in the same solution in the presence of
0.1% DNAse and 0.05% trypsin inhibitor, centrifuged and resuspended
in BME medium containing 10% calf fetal serum and 25 mMKCl. Cell
suspensions with the density of 1.5 · 106 cell/ml were cultivated in 24
well plates in 5% CO2 at 37 C. After 24 h the cell proliferation was
stopped by adding 10 lM arabinosylcytosine (Sigma, USA) On 7–8
days of cultivation the culture medium was changed to BME with
3% calf fetal serum and cells were subjected to the viability tests.
SH-SY5Y neuroblastoma cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% FBS and antibiotics in a 5%
CO2 humidiﬁed atmosphere at 37 C.
2.4. Mitochondrial activity assay
Cells were plated at a density of 10000 cells per well in 96-well plates.
The aliquots of amyloid samples were added to the wells (100 ll) and
cerebellar granular neurons were incubated for 16 h, while SH-SY5Y
cells for 24 h, respectively. 10 ll of MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) labelling reagent (Roche Applied
Sciences, Germany) was added to cerebellar granular neurons and tet-
razolium salt WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tet-
razolio]-1,3-benzene disulfonate) (Roche Applied Sciences, Germany)
to SH-SY5Y cells, respectively. The samples were incubated for further
4 h. 100 ll of solubilization mixture (10% SDS, 0.01 M HCl) was
added to each well and the samples were incubated overnight. Absor-
bance of formazan at 570 nm was measured with an ELISA plate
reader (Labsystems, USA).
2.5. Atomic force microscopy
Atomic force microscopy (AFM) measurements were performed on
a PICO SPM microscope (Molecular Imaging, USA) in a tapping
mode using a 100 nm scanner with acoustically driven cantilevers. Can-
tilevers carried etched silicon probes of TESP model with diameter of
10 nm and less (Digital Instruments, USA) were operated at resonance
frequencies in 170–190 or 320–370 kHz range. Scanning resolution was
512 · 512 pixels. Height, amplitude and phase data were collected
simultaneously. The scanning was performed in trace and retrace to
avoid the scan artefacts. Images were ﬂattened and plane adjusted. Be-
fore imaging, the scanner was calibrated by using a standard 1 nm cal-
ibration grid (Molecular Imaging, USA) in the x–y plane and
measuring atomic steps on a highly oriented pyrolytic graphite surface
in the z-axis. For ambient imaging, amyloid samples were prepared as
described previously [21].2.6. Measurements of particle dimensions
The dimensions of individual particles were measured in multiple
cross-sections of AFM height images by using PicoPlus software
(Molecular Imaging, USA). The distribution of z-heights of all parti-
cles adhered from the sample to the mica surface was evaluated by
the grain analysis module of scanning probe image processor (SPIP)software (Image Metrology, Denmark). In each sample we have ana-
lyzed by the SPIP grain module 3–4 mica areas of 1.5 · 1.5 lm size
with 4000–8000 particles in each.
The volume of the oligomeric particle was calculated by equation
[24,25] where d is the diameter of the particle approximated as spher-
ical cup and measured at its half height, h
V AFM ¼ phd2=8. ð1Þ
The molecular volume of monomeric albebetin was estimated using
equation
V m ¼ ðM0=N 0ÞðV 1 þ pV 2Þ; ð2Þ
whereM0 is the protein molecular weight, N0 is Avogadro’s number, p
is the extent of protein hydration (0.4 mol H2O/mol protein), and V1
and V2 are the partial speciﬁc volumes of protein (0.74 cm
3 g1) and
water (1 cm3 g1) molecules, respectively [24,25]. The number of albeb-
etin monomers in oligomers was determined by the ratio:
n ¼ V AFM=V m. ð3Þ
To evaluate the accuracy of our measurements, we used the refer-
ence samples such as spherical latex particles with circa 1.5 nm diam-
eter and single wall carbon nanotubes with circa 1 nm diameter as
well as applied the tip deconvolution module of the SPIP software (Im-
age Metrology, Denmark) accounting for the geometry of the tips.
Measurements of the reference samples conﬁrmed the conclusion of
[8,24,25], that a spherical cap approximation suﬃciently describes pro-
tein particles. Processing images with the SPIP tip deconvolution mod-
ule indicated that the shape of the tip did not produce topological
distortions.
2.7. Statistical analysis
Statistical analysis of cell viability measurements was performed by
Student’s paired t test. Results are expressed as mean ± S.D. P < 0.05
was considered statistically signiﬁcant.3. Results
3.1. Spectroscopic characterisation of cross-b-sheet containing
amyloid
The ﬁbrillation of albebetin proceeds within hours of incu-
bation at physiological pH and 57 C. The overall kinetics
was monitored by thioﬂavine T ﬂuorescence assay as this dye
has a propensity to bind to cross-b-sheet containing amyloid
[22,23]. The results are shown in Fig. 1, indicating that after
a short lag-phase of ca. 2 h the development of cross-b-sheet
structure takes place in amyloid aggregates which results in
signiﬁcant enhancement of thioﬂavine T dye ﬂuorescence.
The thioﬂavine T ﬂuorescence increases by 4–5 fold at the pla-
teau level reached after ca. 15 h and remained in this range
upon further incubation up till weeks (data not shown).
In addition, ABB ﬁbrillation was characterized by Congo
red assay as this dye is also speciﬁcally binds to amyloid struc-
tures; the results are shown in Fig. 1B. Freshly dissolved pro-
tein and the oligomers formed during the lag phase in the
kinetic do not bind Congo red, which does not aﬀect the posi-
tion of the dye absorbance spectra. The binding of Congo red
by the oligomers formed after 6 h of incubation and by ﬁbrils
assembled after 24 h leads to the red shift of Congo red absor-
bance by 9 and 17 nm, respectively.
In order to characterise the changes of the secondary struc-
ture during amyloid assembly the far UV CD spectra were re-
corded as shown in Fig. 1C. Due to a high degree of
conformational ﬂexibility of albebetin the spectra of freshly
dissolved protein as well as of the sample incubated for 2 h
are characterized by a pronounced signal at 205–210 nm corre-
sponding to random-coil. The formation of the later oligomers
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Fig. 1. Albebetin ﬁbrillation monitored by spectroscopic techniques.
Protein was incubated at pH 7.3 and 57 C (see Section 2). (A)
Thioﬂavin T binding to albebetin amyloid. I/I0 is a relative ﬂuores-
cence of thioﬂavin T, where I refers to the dye bound to amyloid and I0
to free dye in solution. (B) Congo red binding to albebetin amyloid.
Congo red spectrum in the presence of freshly dissolved protein is
denoted by black line, in the presence of the 2 h sample by open
triangles, the 6 h sample – by ﬁlled circles and the 24 h sample – by
open circles. Insertion shows the long wavelength shift of the spectra of
Congo red dye bound to amyloid during its incubation. (C) Far UV
CD spectra of albebetin amyloid. The spectra are denoted as (B).
V. Zamotin et al. / FEBS Letters 580 (2006) 2451–2457 2453(6 h) and ﬁbrils (24 h of incubation), by contrast, is manifested
in signiﬁcant changes of the shape of the far-UV CD spectra in
which the minimum at 216–220 nm become more pronounced
revealing a substantial increase of the b-sheet content
(Fig. 1C). Due to heterogeneity of the sample and the presence
of the residual amount of monomeric albebetin even after 24 hof incubation, the CD signal deviates from the classical b-sheet
CD spectrum indicating the presence of some other types of
secondary structure.
3.2. AFM imaging of amyloid oligomers and ﬁbrils
The molecular species corresponding to the lag- (2 h),
growth-phases (6 h) as well as to the plateau level (24 and
48 h) of incubation (Fig. 1) were subjected to detail AFM anal-
ysis. Their AFM images are presented in Fig. 2. In the ﬁrst two
samples oligomers were dominant species. There were also
some non-structured aggregates in both samples; similar aggre-
gates were also observed in freshly dissolved protein and
among mature ﬁbrils. After 6 h of incubation the ﬁbrils have
not yet been observed, even in a small number. The plateau
of the kinetics corresponds to the formation of ﬁbrillar species.
After 24 h of incubation the ﬁbrils were characterized by
1.5 nm height in the AFM cross-sections, which is a character-
istic dimension of single protoﬁlaments [15]; their length varied
from ca. 10 to ca. 500 nm. On 48 h of incubation the ﬁbrils
have matured; they signiﬁcantly thickened due to lateral
assembly of protoﬁlaments, their widths varied from 2–3 up
to 10–15 nm and their lengths grew to a few microns.
The dimensions of oligomeric species shown in Fig. 2A and
B were analyzed by both manual AFM cross-sections of the
individual particles and by measuring of all particles within
the AFM imaging ﬁeld with the grain analysis SPIP program.
The distributions of the particle heights are presented in Fig. 3.
Both techniques of height measurements showed consistent re-
sults (compare Fig. 3A and B with the corresponding inser-
tions). The distribution after 2 h of incubation (Fig. 3A) is
centred at 0.8–1.0 nm with the diameter measured at half-
height of 20 ± 5 nm. These species are composed of ca. 10–
15 monomers estimated by Eqs. (1)–(3).
The major population of species after 6-h incubation
(Fig. 3B) is characterized by 1.6–2.2 nm heights with the
diameter at half-height of 30 ± 5 nm. These oligomers are
comprised of 25–40 molecules estimated as described above.
Similar oligomers are also observed after 12 h of incubation
corresponding to the kinetic growth phase (Fig. 1). Both olig-
omeric size distributions are broad reﬂecting heterogeneity of
amyloid samples that was conﬁrmed by native gel electropho-
resis demonstrating the ladder of oligomeric species in both
cases (data not shown). The stability of the oligomers was as-
sessed after 24 h incubation in the culture medium corre-
sponding to the cytotoxicity tests; measurements of their
dimensions by grain analysis SPIP module showed the same
distributions.3.3. Eﬀect of amyloid on cell viability
The aliquots containing amyloid structures of albebetin were
added to two cell types, cerebellar granular neurons and SH-
SY5Y cells. Cell survival in the presence of amyloid was as-
sessed by the ability of mitochondrial dehydrogenases to reduce
tetrazolium salt in viable cells. The results are presented in
Fig. 4. In control measurements we have shown that there
was no diﬀerence in the viability of untreated cells and cells
with added buﬀer used for amyloid incubation. Ab25–35 amy-
loid structures and apoptotic agent D-sphingosine were used
as positive controls of induced cytotoxicity. Upon addition
of Ab25–35 amyloid the survival of granular neurons decreased
by ca. 45% (Fig. 4A). Similar eﬀect was observed with SH-
Fig. 2. AFM imaging of albebetin amyloidogenesis. Amyloid samples after 2 h (A) and 6 h (B) incubation (see Section 2) containing oligomers; after
24 h (C) and 48 h (D) containing protoﬁlaments and mature ﬁbrils, respectively. Cross-sections of individual species are shown by white arrows.
Insertions in the left lower corners in each ﬁgure show the corresponding cross-sections. The right lower corner insertion in (B) shows three-
dimensional image of spherical oligomers. z-scale is 3 nm in (A), 5 nm in (B), 10 nm in (C) and 20 nm in (D).
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Fig. 3. Distributions of z-heights of albebetin oligomers. The sample of albebetin after 2 h (A) and 6 h (B) of incubation (see Section 2).
Measurements were carried out by using SPIP software. Insertions in both ﬁgures show the distributions measured by manual cross-section analysis.
Counts of grains are shown in percentage.
2454 V. Zamotin et al. / FEBS Letters 580 (2006) 2451–2457SY5Y cells in the presence of D-sphingosine (Fig. 4B). Mono-
meric albebetin and the samples containing smaller 10–15-mers
oligomers did not aﬀect cell viability. By contrast, the larger
25–40-mers oligomers produced the cytotoxic eﬀect. The cell
viability depends on the concentration of added amyloid
(Fig. 4). The viability of granular neurons decreases by 25–30% and SH-SY5Y by ca. 15% in the presence of 50 lM ali-
quot of amyloid oligomers. Amyloid protoﬁlaments and ﬁbrils
shown in Fig. 2C and D did not produce the cytotoxic eﬀect on
SH-SY5Y cells, however we observed small but statistically
signiﬁcant (P < 0.01) decrease of viability by ca. 5% in granu-
lar neuronal culture.
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Fig. 4. Eﬀect of albebetin amyloid on viability of cerebellar granular neurons (A) and SH-SY5Y neuroblastoma cells (B). Time of incubation of
albebetin amyloid is shown along x-axis. White bars correspond to addition of 5 lM albebetin solution and black bars to 50 lM. Control
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Fibrillation process of albebetin, shown to be in a molten
globule conformation under neutral pH [17–20], involves the
formation of multiple amyloid species, among which at least
two types of oligomers can be identiﬁed. The ﬁrst ones are
10–15-mers assembled during the lag phase of incubation.
The lack of thioﬂavine T and Congo red dye binding and
the shape of the far UV CD spectrum indicate that cross-b-
sheet structure has not yet been developed. The similarity of
the far UV CD spectra of monomeric albebetin and the early
oligomers indicates that the latter are most likely comprised
of molten globule albebetin (Fig. 1C). This type can be referred
to pivotal oligomers described previously [21] which either un-
dergo conversion into the larger aggregates or coexist with ﬁ-
brils. The second type includes oligomers of 25–40-mers size;
their binding to amyloid speciﬁc dyes thioﬂavine T and Congo
red and the development of far UV CD spectrum similar to the
ﬁbrillar CD signal indicate the formation of cross-b-sheet
structure. Both types of oligomers exhibit similar round-
shaped morphology in AFM images which is commonly
associated with preﬁbrillar amyloid [1–5]. Here we have
demonstrated that only the second enlarged type of oligomersproduce cytotoxic eﬀect on two kinds of neuronal cells. The
current observations of exerted amyloid cytotoxicity by albeb-
etin amyloid are schematically summarized in Fig. 5. Residual
cytotoxic eﬀect noticed during the early ﬁbrillation stage
(Fig. 4) can be either due to non-speciﬁc mechanical damage
of the cells by ﬁbrils or can be associated with some remaining
fraction of toxic oligomeric species.
The ﬁbrillation of albebetin is consistent with the nucleation
conformational conversion model of amyloid formation, in
which less structured oligomers are converted into the amyloid
competent type consequently assembling into ﬁbrils [26–28].
This is in contrast to the nucleation model in which primary
nuclei serve as templates initiating rapid amyloid polymeriza-
tion [29]. Hierarchy of oligomers undergoing consequent struc-
tural conversion with ﬁbril formation at the end has been
observed for some other proteins [30,31].
In a light of hypothesis that amyloid acts via common cyto-
toxic mechanisms [6] it is of crucial importance to provide clear
structural description of cytotoxic oligomeric species discrimi-
nating them from non-toxic amyloid oligomeric precursors.
While the soluble oligomers from diﬀerent proteins are clearly
varied signiﬁcantly in their size, our results support the view
that the development of cross-b-sheet core is essential for
Fig. 5. Schematic presentation of albebetin amyloid pathways and
exerted cytotoxicity. Grey arrows show the pathways of amyloid
assembly, red ones – cytotoxic eﬀect on cells produced by amyloid.
Insertions show AFM images of amyloid structures which are also
presented schematically. Albebetin fold is shown by yellow arrows and
green columns corresponding to b-strands and a-helices, respectively.
2456 V. Zamotin et al. / FEBS Letters 580 (2006) 2451–2457exerted cytotoxicity. Indeed, cross-b-sheet structure is critical
both for the interaction of amyloid with cellular receptors
[32] and lipid membranes [11,33] implicated in cytotoxicity.
The size or stoichiometry of oligomers can be a secondary fac-
tor depending on the particular polypeptide sequence though
critical for the stabilising the cross-b-sheet structure within
the molecular assembly.
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